Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SANTHERA PHARMACEUTICALS HOLDING AG

(SANN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company is involved in the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases. The Company’s products include Catena and Raxone brands, which are primarily implemented in the symptomatic treatment of Leber's Hereditary Optic Neuropathy (LHON) diseases. Sathera Pharmaceuticals Holding AG operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.

Number of employees : 91 people.
Sales per Business
20192020Delta
Pharmaceutical Products75.38100%15.01100% -80.09%
CHF in Million
Sales per region
20192020Delta
European Union75.1899.7%15.00100% -80.05%
Rest of the World0.200.3%0.010% -96.43%
CHF in Million
Managers
Name Title Age Since
Dario Eklund Chief Executive Officer 53 2019
Andrew P. Smith, Dr. Chief Financial Officer 58 2020
Martin Gertsch Vice Chairman 56 2017
Philipp Gutzwiller Independent Director 53 2017
Elmar J. Schnee, Dr. Chairman 62 2017
Patrick Volkert Vink, Dr. Independent Director 58 2017
Oliver Strub Secretary, Executive VP & General Counsel 58 2006
Günther Metz, Dr. Senior Vice President-Business Development 63 2004
Members of the board
Name Title Age Since
Elmar J. Schnee, Dr. Chairman 62 2017
Thomas Meier, Dr. Director 59 2019
Martin Gertsch Vice Chairman 56 2017
Philipp Gutzwiller Independent Director 53 2017
Patrick Volkert Vink, Dr. Independent Director 58 2017
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 54,607,810 44,663,919 81.8% 1,301,075 2.4% 81.8%
Shareholders
NameEquities%
Idorsia Ltd 7,482,259 13.7%
Santhera Pharmaceuticals Holding AG 5,455,622 9.99%
OrbiMed Advisors Private Equity 1,712,000 3.13%
Ernesto Bertarelli 1,632,774 2.99%
Armistice Capital LLC 494,145 0.90%
Credit Suisse Asset Management (Schweiz) AG 463,500 0.85%
IFS Independent Financial Services AG 350,000 0.64%
TOBAM SAS 172,459 0.32%
Zürcher Kantonalbank (Investment Management) 139,478 0.26%
UBS Asset Management Switzerland AG 125,500 0.23%
Holdings
NameEquities%Valuation
SANTHERA PHARMACEUTICALS HOLDING AG (SANN) 5,455,622 9.99% 7,940,876 USD
Company contact information
Santhera Pharmaceuticals Holding AG
Hohenrainstrasse 24
Pratteln, Basel-Landschaft (Basle Country) 4133

Phone : +41.61.906.89.50
Fax : +41.61.906.89.51
Web : http://www.santhera.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Santhera Pharmaceuticals Holding AG